These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36180805)

  • 1. The cytoprotective role of GM1 ganglioside in Huntington disease cells.
    Hart HS; Valentin MA; Peters ST; Holler SW; Wang H; Harmon AF; Holler LD
    Mol Biol Rep; 2022 Dec; 49(12):12253-12258. PubMed ID: 36180805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired ganglioside metabolism in Huntington's disease and neuroprotective role of GM1.
    Maglione V; Marchi P; Di Pardo A; Lingrell S; Horkey M; Tidmarsh E; Sipione S
    J Neurosci; 2010 Mar; 30(11):4072-80. PubMed ID: 20237277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-modifying effects of ganglioside GM1 in Huntington's disease models.
    Alpaugh M; Galleguillos D; Forero J; Morales LC; Lackey SW; Kar P; Di Pardo A; Holt A; Kerr BJ; Todd KG; Baker GB; Fouad K; Sipione S
    EMBO Mol Med; 2017 Nov; 9(11):1537-1557. PubMed ID: 28993428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).
    Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA
    Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Making (anti-) sense out of huntingtin levels in Huntington disease.
    Evers MM; Schut MH; Pepers BA; Atalar M; van Belzen MJ; Faull RL; Roos RA; van Roon-Mom WM
    Mol Neurodegener; 2015 Apr; 10():21. PubMed ID: 25928884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice.
    Di Pardo A; Maglione V; Alpaugh M; Horkey M; Atwal RS; Sassone J; Ciammola A; Steffan JS; Fouad K; Truant R; Sipione S
    Proc Natl Acad Sci U S A; 2012 Feb; 109(9):3528-33. PubMed ID: 22331905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of overexpression of huntingtin proteins on mitochondrial integrity.
    Wang H; Lim PJ; Karbowski M; Monteiro MJ
    Hum Mol Genet; 2009 Feb; 18(4):737-52. PubMed ID: 19039036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Huntington's disease does not appear to increase the risk of diabetes mellitus.
    Boesgaard TW; Nielsen TT; Josefsen K; Hansen T; Jørgensen T; Pedersen O; Nørremølle A; Nielsen JE; Hasholt L
    J Neuroendocrinol; 2009 Sep; 21(9):770-6. PubMed ID: 19602103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis.
    Kim YJ; Yi Y; Sapp E; Wang Y; Cuiffo B; Kegel KB; Qin ZH; Aronin N; DiFiglia M
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12784-9. PubMed ID: 11675509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juvenile Huntington's Disease Skin Fibroblasts Respond with Elevated Parkin Level and Increased Proteasome Activity as a Potential Mechanism to Counterbalance the Pathological Consequences of Mutant Huntingtin Protein.
    Aladdin A; Király R; Boto P; Regdon Z; Tar K
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
    Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
    J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple phenotypes in Huntington disease mouse neural stem cells.
    Ritch JJ; Valencia A; Alexander J; Sapp E; Gatune L; Sangrey GR; Sinha S; Scherber CM; Zeitlin S; Sadri-Vakili G; Irimia D; Difiglia M; Kegel KB
    Mol Cell Neurosci; 2012 May; 50(1):70-81. PubMed ID: 22508027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease.
    Wellington CL; Ellerby LM; Gutekunst CA; Rogers D; Warby S; Graham RK; Loubser O; van Raamsdonk J; Singaraja R; Yang YZ; Gafni J; Bredesen D; Hersch SM; Leavitt BR; Roy S; Nicholson DW; Hayden MR
    J Neurosci; 2002 Sep; 22(18):7862-72. PubMed ID: 12223539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic Huntington Alters BMP Signaling and Synaptic Growth through Local Disruptions of Endosomal Compartments.
    Akbergenova Y; Littleton JT
    J Neurosci; 2017 Mar; 37(12):3425-3439. PubMed ID: 28235896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models.
    Ehrnhoefer DE; Duennwald M; Markovic P; Wacker JL; Engemann S; Roark M; Legleiter J; Marsh JL; Thompson LM; Lindquist S; Muchowski PJ; Wanker EE
    Hum Mol Genet; 2006 Sep; 15(18):2743-51. PubMed ID: 16893904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of mutant huntingtin at serine 116 modulates neuronal toxicity.
    Watkin EE; Arbez N; Waldron-Roby E; O'Meally R; Ratovitski T; Cole RN; Ross CA
    PLoS One; 2014; 9(2):e88284. PubMed ID: 24505464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wild type Huntingtin reduces the cellular toxicity of mutant Huntingtin in mammalian cell models of Huntington's disease.
    Ho LW; Brown R; Maxwell M; Wyttenbach A; Rubinsztein DC
    J Med Genet; 2001 Jul; 38(7):450-2. PubMed ID: 11432963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometric identification of novel posttranslational modification sites in Huntingtin.
    Dong G; Callegari E; Gloeckner CJ; Ueffing M; Wang H
    Proteomics; 2012 Jun; 12(12):2060-4. PubMed ID: 22623107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotype onset in Huntington's disease knock-in mice is correlated with the incomplete splicing of the mutant huntingtin gene.
    Franich NR; Hickey MA; Zhu C; Osborne GF; Ali N; Chu T; Bove NH; Lemesre V; Lerner RP; Zeitlin SO; Howland D; Neueder A; Landles C; Bates GP; Chesselet MF
    J Neurosci Res; 2019 Dec; 97(12):1590-1605. PubMed ID: 31282030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggregation landscapes of Huntingtin exon 1 protein fragments and the critical repeat length for the onset of Huntington's disease.
    Chen M; Wolynes PG
    Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4406-4411. PubMed ID: 28400517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.